Data / Drug companies / Adapalene
Adapalene: 34 companies and 52 products in the FDA NDC directory
Adapalene is listed in the FDA National Drug Code Directory by 34 companies, with 52 products in commercial distribution. 48 of the products (92.3%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are gel; cream; swab, and the newest product started marketing on November 1, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 34
- Products
- 52
- Generic (ANDA) products
- 48 (92.3%)
- Application numbers
- 11
- Routes
- Topical
- Brand names
- PanOxyl, Effaclar, Differin, Differin, Curist Acne Relief
- openFDA record search
- api.fda.gov
Companies that list adapalene
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Walgreen Company | 4 | gel | Generic drugs (ANDA) | November 1, 2026 |
| Yyba Corp | 4 | gel | Generic drugs (ANDA) | March 1, 2026 |
| Kenvue Brands LLC | 3 | gel | Generic drugs (ANDA) | November 25, 2025 |
| L'Oreal USA Products Inc | 3 | gel | Generic drugs (ANDA) | September 16, 2024 |
| CVS Woonsocket Prescription Center, Incorporated | 2 | gel | Generic drugs (ANDA) | September 15, 2026 |
| Crown Laboratories | 2 | gel | Generic drugs (ANDA) | August 8, 2025 |
| Galderma Laboratories, L.P. | 2 | gel | New drug applications (NDA) | July 8, 2016 |
| Glenmark Therapeutics Inc., USA | 2 | gel | Generic drugs (ANDA) | March 10, 2023 |
| Kroger Company | 2 | gel | Generic drugs (ANDA) | September 15, 2026 |
| Meijer, Inc. | 2 | gel | Generic drugs (ANDA) | September 15, 2026 |
| Sun Pharmaceutical Industries, Inc. | 2 | gel | Generic drugs (ANDA) | January 14, 2022 |
| Topco Associates LLC | 2 | gel | Generic drugs (ANDA) | September 15, 2026 |
| Actavis Pharma, Inc. | 1 | gel | Generic drugs (ANDA) | October 27, 2014 |
| Alchemee, LLC | 1 | gel | Generic drugs (ANDA) | November 16, 2023 |
| Alembic Pharmaceuticals Inc. | 1 | gel | Generic drugs (ANDA) | June 22, 2020 |
| Alembic Pharmaceuticals Limited | 1 | gel | Generic drugs (ANDA) | March 26, 2025 |
| Amerisource Bergen | 1 | gel | Generic drugs (ANDA) | February 26, 2024 |
| Bryant Ranch Prepack | 1 | cream | Generic drugs (ANDA) | June 30, 2010 |
| Bryant Ranch Prepack | 1 | cream | Generic drugs (ANDA) | June 30, 2010 |
| CVS Pharmacy | 1 | gel | Generic drugs (ANDA) | August 1, 2019 |
| Call Inc. (DBA Rochester Pharmaceuticals) | 1 | swab | Generic drugs (ANDA) | February 4, 2019 |
| Cardinal Health 110, LLC. DBA Leader | 1 | gel | Generic drugs (ANDA) | March 17, 2024 |
| Dolgencorp, Inc. (dollar General & Rexall) | 1 | gel | Generic drugs (ANDA) | November 29, 2019 |
| E. Fougera & Co. a Division of Fougera Pharmaceuticals, LLC | 1 | cream | Generic drugs (ANDA) | June 30, 2010 |
| Little Pharma, Inc. | 1 | gel | Generic drugs (ANDA) | August 15, 2022 |
| Mayne Pharma | 1 | gel | Authorized generics (NDA) | February 26, 2024 |
| Meijer Distribution Inc | 1 | gel | Generic drugs (ANDA) | November 29, 2019 |
| P & L Development, LLC | 1 | gel | Generic drugs (ANDA) | November 30, 2023 |
| Padagis Israel Pharmaceuticals Ltd | 1 | cream | Authorized generics (NDA) | October 26, 2010 |
| Rite Aid Corporation | 1 | gel | Generic drugs (ANDA) | April 15, 2024 |
| Rugby Laboratories | 1 | gel | Generic drugs (ANDA) | February 20, 2024 |
| Safeway | 1 | gel | Generic drugs (ANDA) | January 31, 2024 |
| Target Corporation | 1 | gel | Generic drugs (ANDA) | July 19, 2024 |
| Walmart Inc. | 1 | gel | Generic drugs (ANDA) | June 6, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Gel | 47 | 90.4% |
| Cream | 4 | 7.7% |
| Swab | 1 | 1.9% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 48 | 92.3% |
| Authorized generics (NDA) | 2 | 3.8% |
| New drug applications (NDA) | 2 | 3.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Retinoid | 52 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.